Nektar’s opioid analgesic meets endpoints in Phase 3 Study of chronic pain
28 March 2017 | By Niamh Marriott, Junior Editor
Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 efficacy study of NKTR-181, an opioid analgesic...
List view / Grid view
News
Butterworth Laboratories Ltd is delighted to announce expansion
28 March 2017 | By Butterworth Laboratories Ltd
Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in Hampton, Middlesex as part of a project to expand UK laboratory operations by 15% in 2017...
Covectra launches anti-counterfeit barcode labelling system
27 March 2017 | By Steve Bremer, Managing Editor
Covectra has launched an anti-counterfeit, tamper-evident, barcode labelling system
EPSRC commits £15 million for formulation manufacturing research
New research projects that aim to improve the complex formulation processes used to manufacture products such as toothpastes, inhalers, films that coat solar cells and pharmaceuticals are to receive significant funding from the Engineering and Physical Sciences Research Council (EPSRC).
IntelliCyt Cy-Clone™ PLUS
27 March 2017 | By IntelliCyt Corporation
Cy-Clone PLUS together with the iQue Screener PLUS platform uses the power of high throughput flow cytometry...
Karolinska Development company enrols first patient Phase Ib/IIa hepatic encephalopathy trial
27 March 2017 | By Niamh Marriott, Junior Editor
Umecrine Cognition AB announced the inclusion of the first patient in a clinical Phase Ib/IIa study of GR3027, to treat Hepatic Encephalopathy...
Shimadzu’s New Cannabis Analyser for Potency Provides Effortless Determination of Cannabinoid Content
24 March 2017 | By Shimadzu Scientific Instruments
Shimadzu Scientific Instruments (SSI) announces the release of its new Cannabis Analyser for Potency. This high performance liquid chromatograph (HPLC) is the first-ever instrument designed specifically for quantitative determination of cannabinoid content...
NICE asks BMS for more data before approving cancer drug
24 March 2017 | By Niamh Marriott, Junior Editor
NICE has asked Bristol Myers Squibb, who manufacture nivolumab (Opdivo), to provide more information on its effectiveness for treating Hodgkin lymphoma...
Pegasus® BT: Benchtop GC-TOFMS
23 March 2017 | By LECO
LECO Corporation’s latest innovation for the GC-MS marketplace - the Pegasus® BT - was introduced at ASMS in 2016. The Pegasus BT gives users all of the data they could ever need from a single sample run with an innovative new TOFMS platform...
Akcea and Ionis’ familial chylomicronaemia syndrome study a success
23 March 2017 | By Niamh Marriott, Junior Editor
Akcea Therapeutics' pivotal Phase 3 study of volanesorsen reduced triglyceride levels in patients with familial chylomicronaemia syndrome...
A focus on supply chain security and anti-counterfeiting at Pharmaceutical Logistics
23 March 2017 | By Pharmaceutical Logistics
Mundipharma, GS1, GIRP and TAPA release presentations ahead of the 11th annual Pharmaceutical Logistics Conference which returns to London 18th & 19th May 2017...
New formulation of FDA-approved drug may help treat Niemann-Pick Type C disease
23 March 2017 | By Niamh Marriott, Junior Editor
New research from the University of Notre Dame may lead to a therapy for NPC, using an existing FDA-approved drug in a novel approach to treatment...
Shimadzu’s New Triple Quadrupole GCMS Achieves World’s Highest Sensitivity Down to Femtogram Level
23 March 2017 | By Shimadzu Scientific Instruments
Shimadzu Scientific Instruments announces the release of the new GCMS-TQ8050 triple quadrupole gas chromatograph mass spectrometer...
Waters adds METLIN MS/MS Library to Progenesis Software, Extending Metabolomics Capabilities
23 March 2017 | By Waters Corporation
Waters Corporation announces the Waters® METLIN® MS/MS Library for Progenesis® QI, which offers implementation of a METLIN library directly within Progenesis QI Software for use with Waters’ high resolution mass spectrometry (MS) systems. This library plug-in to Progenesis QI enhances metabolomics researchers’ ability to confidently identify metabolites in complex samples…
Injectable drug delivery market worth US$624.50 billion by 2021
23 March 2017 | By Niamh Marriott, Junior Editor
According to a new report, the global injectable drug delivery market is projected to reach US$624.50 Billion by 2021 from US$362.38 billion in 2016...
